Trinity Biotech shares soar on improved revenue outlook for HIV test

Read Time:5 Second

Shares of Trinity Biotech rallied after the company boosted the revenue outlook for its rapid HIV test.

About Post Author

Happy

0 %

Sad

0 %

Excited

0 %

Sleepy

0 %

Angry

0 %

Surprise

0 %

The tech industry’s need for more power for data centers running artificial intelligence is now so desperate that companies are...

One fund manager sees “more cons than pros” if the companies were to combine, after the Wall Street Journal reported...

Boeing Co. said that Ted Colbert — its head of defense, space and security — would leave the company on...

Michelle Bowman was the first Federal Reserve governor to dissent from an interest-rate decision since 2005.

Micron shares have shed most of their 2024 gains, but memory pricing could improve in the coming months, Citi says.

That’s in part because most of his $700 million contract is deferred. Still, his stats this season are worth over...